{
    "root": "2f12eda2-6bae-041a-e063-6294a90ac968",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Exemestane",
    "value": "20250226",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CROSPOVIDONE (120 .MU.M)",
            "code": "68401960MK"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "EXEMESTANE",
            "code": "NY22HMQ4BX"
        }
    ],
    "indications": "exemestane tablets aromatase inhibitor indicated : adjuvant treatment postmenopausal women estrogen-receptor positive early breast cancer received two three years tamoxifen switched exemestane completion total five consecutive years adjuvant hormonal therapy ( 14.1 ) . treatment advanced breast cancer postmenopausal women whose disease progressed following tamoxifen therapy ( 14.2 ) .",
    "contraindications": "recommended dose : one 25 mg tablet daily meal ( 2.1 ) .",
    "warningsAndPrecautions": "exemestane tablets , usp white off-white , round , biconvex , bevel-edged , film-coated tablet engraved 'us ' one face plain . exemestane tablets packaged hdpe bottles child-resistant screw cap . bottle 30 tablets ndc 0832-0595-30",
    "adverseReactions": "exemestane contraindicated patients known hypersensitivity excipients .",
    "indications_original": "Exemestane tablets are an aromatase inhibitor indicated for: adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to exemestane for completion of a total of five consecutive years of adjuvant hormonal therapy ( 14.1 ). treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy ( 14.2 ).",
    "contraindications_original": "Recommended Dose: One 25 mg tablet once daily after a meal ( 2.1 ).",
    "warningsAndPrecautions_original": "Exemestane tablets, USP are a white to off-white, round, biconvex, bevel-edged, film-coated tablet engraved with 'US' on one face and plain on the other.\n                  Exemestane tablets are packaged in HDPE bottles with a child-resistant screw cap.\n                  \n                     \n                     \n                     \n                        \n                           Bottle of 30 tablets\n                           NDC 0832-0595-30",
    "adverseReactions_original": "Exemestane is contraindicated in patients with a known hypersensitivity to the drug or to any of the excipients."
}